Novartis Pharmaceuticals Corporation
88
Plan:
11
78
89
0
10
20
30
40
50
60
70
80
90
100
For the average 401k participant, the 1 point difference between this plan's BrightScope Rating (88) and the top rated plan (89) could equate to:
[How is this calculated?]
[How is this calculated?]
1 additional year of workThe delay in retirement calculations apply solely to this defined contribution plan and do not take into account other retirement plans and programs offered by this employer.
Retirement Plan Description
Novartis Pharmaceuticals Corporation Investment Savings Plan is a defined contribution plan with a profit-sharing component and 401k feature. This plan has a BrightScope Rating of 88, placing it in the top 15% of all plans in its peer group. This plan is also in the top 15% of plans for Account Balances, Company Generosity, Investment Menu Quality, Salary Deferral, and Total Plan Cost. Novartis Pharmaceuticals Corporation Investment Savings Plan currently has over 25,500 active participants and over $3.3B in plan assets.
Retirement Plan Details
| Address |
230 Park Avenue, 21st Floor
New York, NY 10169 |
| Industry | Manufacturing |
| Administrator | William A. Flannery, Exec Director |
| Net Plan Assets | $3,290,000,000 |
| Total Participants | 26,000 |
| Avg Account Balance | $130,000 |
Compare Other Companies in Peer Group
| Amgen | 89.0 |
| Bayer | 87.4 |
| Bristol-Myers Squibb Company | 87.2 |
| Merck & Co. | 83.9 |
| Merck & Co. | 83.5 |
| Eli Lilly and Company | 79.2 |
Comments